BIOMAT Database Logo BIOMAT Database Logo

Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus. 2014

Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Department of Endocrinology, Yishui People's Hospital, Linyi, Shandong Province, China.

OBJECTIVE To investigate prospectively the insulin dose requirements of Chinese patients with type 2 diabetes mellitus treated with either multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII) therapy during a 2-week therapeutic intervention. METHODS Patients with type 2 diabetes mellitus were randomly assigned to MDI or CSII therapy. The effects of the two treatment methods were determined based on blood glucose parameters, total daily insulin dose and rates of hypoglycaemia. RESULTS A total of 609 patients were enrolled in the study. Glycaemic goals were achieved after a mean ± SD of 6.90 ± 2.10 and 5.44 ± 2.22 days' treatment in the MDI and CSII groups, respectively. Once stabilized, the mean ± SD total daily insulin doses were 37.12 ± 10.19 IU and 32.58 ± 8.78 IU for the MDI and CSII groups, respectively. Once stabilized, the mean ± SD total basal and bolus doses were 19.46 ± 7.95 IU/day and 17.66 ± 3.53 IU/day for the MDI group, and 22.79 ± 7.55 IU/day and 9.81 ± 2.64 IU/day for the CSII group, respectively. There were significant differences in the total, basal and bolus insulin doses between the two groups. CONCLUSIONS CSII therapy may be considered as an effective method to achieve good glycaemic control in Chinese patients with type 2 diabetes mellitus.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus

Related Publications

Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus.
February 2002, The Journal of pediatrics,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion.
February 2023, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes.
June 2019, Journal of paediatrics and child health,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
May 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Insulin therapy in pediatric patients with type I diabetes: continuous subcutaneous insulin infusion versus multiple daily injections.
July 2006, Clinical pediatrics,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
June 2008, Diabetologia,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
January 2007, PharmacoEconomics,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion.
January 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.
January 2010, The Cochrane database of systematic reviews,
Honghong Yang, and Xueyuan Heng, and Cuige Liang, and Xiaomeng Liu, and Wenhua Du, and Shoujie Li, and Yueli Wang, and Qingyu Dong, and Wenxia Li, and Zhenyu Pan, and Qian Gong, and Guanqi Gao
Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
January 2015, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
Copied contents to your clipboard!